Including the voice of people living with viral hepatitis: lessons learned from Japan to accelerate progress towards global hepatitis elimination.


Journal

Tropical medicine and health
ISSN: 1348-8945
Titre abrégé: Trop Med Health
Pays: Japan
ID NLM: 101215093

Informations de publication

Date de publication:
01 Oct 2021
Historique:
received: 06 09 2021
accepted: 20 09 2021
entrez: 2 10 2021
pubmed: 3 10 2021
medline: 3 10 2021
Statut: epublish

Résumé

Despite the growing momentum created by the WHO for eliminating viral hepatitis as a public health threat by 2030, the global response is still slow and more actions are needed to meet the elimination goals, especially in low-income and middle-income countries. Japan is one of a handful of countries currently on track to achieve the WHO hepatitis elimination targets by 2030. To better understand the successful control of viral hepatitis in Japan, it is important to recognize the role of the patient association for viral hepatitis, known as the "Japan Hepatitis Council", which celebrates its 50th anniversary in 2021. The greatest impact of the Japan Hepatitis Council has been in achieving wider access to antiviral treatments for viral hepatitis. The example of Japan and the Japan Hepatitis Council highlights the need for the engagement of civil society and patient groups to ensure equitable access to hepatitis services and to accelerate the global hepatitis elimination.

Identifiants

pubmed: 34598715
doi: 10.1186/s41182-021-00371-7
pii: 10.1186/s41182-021-00371-7
pmc: PMC8485555
doi:

Types de publication

Letter

Langues

eng

Pagination

79

Informations de copyright

© 2021. The Author(s).

Références

Lancet Infect Dis. 2016 Dec;16(12):1325
pubmed: 27998586
J Viral Hepat. 2021 Jan;28(1):12-19
pubmed: 32979881
Lancet Gastroenterol Hepatol. 2018 Jun;3(6):383-403
pubmed: 29599078
Hepatol Res. 2019 Sep;49(9):990-1002
pubmed: 31364248
JHEP Rep. 2019 May 10;1(2):81-89
pubmed: 32039355
Lancet Gastroenterol Hepatol. 2021 Oct;6(10):778-780
pubmed: 34384530

Auteurs

Atsuko Yonezawa (A)

Japan Hepatitis Council, 4-27-5-201 Shimo-ochiai, Shinjuku-ku, Tokyo, 161-0033, Japan. ayonezawa@tokankai.com.

Rebecca Grant (R)

Unité d'Épidémiologie des Maladies Émergentes, Institut Pasteur, 25-28 rue du Dr Roux, 75015, Paris, France.
Sorbonne Université, Paris, France.

Yusuke Shimakawa (Y)

Unité d'Épidémiologie des Maladies Émergentes, Institut Pasteur, 25-28 rue du Dr Roux, 75015, Paris, France. yusuke.shimakawa@gmail.com.

Classifications MeSH